rs201974007
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_001290043.2(TAP2):c.1462-7T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,611,262 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001290043.2 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAP2 | NM_001290043.2 | c.1462-7T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000374897.4 | NP_001276972.1 | |||
TAP2 | NM_018833.3 | c.1462-7T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_061313.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAP2 | ENST00000374897.4 | c.1462-7T>C | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_001290043.2 | ENSP00000364032 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000861 AC: 131AN: 152164Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00113 AC: 270AN: 238990Hom.: 1 AF XY: 0.00104 AC XY: 136AN XY: 130548
GnomAD4 exome AF: 0.00106 AC: 1546AN: 1458980Hom.: 4 Cov.: 36 AF XY: 0.00103 AC XY: 746AN XY: 725738
GnomAD4 genome AF: 0.000860 AC: 131AN: 152282Hom.: 1 Cov.: 32 AF XY: 0.000766 AC XY: 57AN XY: 74452
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
MHC class I deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
TAP2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 02, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at